Alessandra Leprini
About
In The Last Decade
Alessandra Leprini
20 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 756
- Immunology and Allergy 719
- Radiology, Nuclear Medicine and Imaging 601
- Oncology 330
- Cell Biology 291
Countries citing papers authored by Alessandra Leprini
This map shows the geographic impact of Alessandra Leprini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Leprini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Leprini more than expected).
Fields of papers citing papers by Alessandra Leprini
This network shows the impact of papers produced by Alessandra Leprini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Leprini. The network helps show where Alessandra Leprini may publish in the future.
Co-authorship network of co-authors of Alessandra Leprini
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Leprini. A scholar is included among the top collaborators of Alessandra Leprini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Leprini. Alessandra Leprini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer. | 230 |
| 2 | 291 | |
| 3 | 38 | |
| 4 | 10 | |
| 5 | 9 | |
| 6 | 17 | |
| 7 | Differential cation regulation of the alpha 5 beta 1 integrin-mediated adhesion of leukemic cells to the central cell-binding domain of fibronectin. | 15 |
| 8 | 62 | |
| 9 | 230 | |
| 10 | 10 | |
| 11 | 130 | |
| 12 | 8 | |
| 13 | 43 | |
| 14 | 6 | |
| 15 | Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression. | 28 |
| 16 | 117 | |
| 17 | 7 | |
| 18 | 183 | |
| 19 | 117 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.